Year: 2025
Type: article
Study design: Case Report
Abstract: Immune thrombocytopenia (ITP) is a rare hematologic disorder characterized by low platelet counts due to an immune-mediated destruction of platelets. While corticosteroids, intravenous immunoglobulin (IVIG) are the mainstays of treatment, a subset of patients may remain refractory to these therapies. Here, we present a case of a 6-year-old girl diagnosed with refractory ITP, who failed to respond to standard therapies but showed a remarkable clinical improvement with avatrombopag, a thrombopoietin receptor agonist.
Source: Frontiers in Immunology
Authors: Antonella Sau, Gianfranco Di Prinzio, Daniela Onofrillo, Anna Caterina Russo, Nicole Santoro, Mauro Di Ianni
Institution: University of Chieti-Pescara
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $3,801
OpenAlex ID: W4409466344